Related Experiment Video
Updated: Jun 4, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
Protein-polymer nanoparticles for nonviral gene delivery
Jianjun Zhang1, Yuguo Lei, Anandika Dhaliwal
1Chemical and Biomolecular Engineering Department, University of California at Los Angeles, California, United States.
Biomacromolecules
|February 18, 2011
Summary
Protein-polymer nanoparticles (nBSA) offer a promising nonviral gene delivery method. These BSA-poly(dimethylamino) ethyl methacrylate nanoparticles efficiently deliver plasmid DNA (pDNA) with comparable or superior results to existing methods.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Nonviral gene delivery vectors are crucial for therapeutic applications.
- Developing efficient and safe nonviral vectors remains a significant challenge.
- Protein-polymer conjugates offer a versatile platform for novel vector design.
Purpose of the Study:
- To synthesize and characterize BSA-poly(dimethylamino) ethyl methacrylate (PDMA) nanoparticles (nBSA) as nonviral gene delivery vectors.
- To evaluate the gene delivery efficiency of nBSA/plasmid DNA (pDNA) polyplexes.
- To explore the influence of nBSA characteristics on gene delivery performance.
Main Methods:
- Synthesis of nBSA nanoparticles using in situ atom transfer radical polymerization (ATRP) with BSA as a macroinitiator.
- Characterization of nBSA particle size (5-15 nm) and surface charge (+8.9 to +22.5).
- Formation and characterization of nBSA/pDNA polyplexes (average diameter ~50 nm) and assessment of transfection efficiencies in cells.
Main Results:
- nBSA nanoparticles were successfully synthesized with tunable size and charge.
- nBSA/pDNA polyplexes demonstrated efficient gene delivery, comparable or superior to PEI.
- nBSA particle characteristics did not significantly impact pDNA complexation or transgene expression, suggesting flexibility in vector design.
Conclusions:
- BSA-PDMA nanoparticles represent a viable alternative for nonviral gene delivery.
- The protein-polymer conjugate approach allows for versatile functionalization of gene delivery vectors.
- Further research into protein-polymer conjugates could lead to improved gene therapy strategies.
